HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Gastrointestinal Oncology

Gastrointestinal oncology is a specialized branch of medicine focused on the diagnosis and treatment of cancers that originate in the digestive system. This encompasses a range of malignancies affecting organs such as the esophagus, stomach, liver, pancreas, gallbladder, small intestine, and colon. These cancers pose significant challenges due to their complex nature and varied clinical presentations. Early detection plays a crucial role in improving outcomes for patients with gastrointestinal cancers. Screening programs, advanced imaging techniques, and innovative diagnostic tools enable healthcare professionals to identify malignancies at earlier, more treatable stages. Common diagnostic modalities include endoscopy, imaging studies such as CT scans and MRI, as well as laboratory tests to assess tumor markers. Treatment strategies for gastrointestinal cancers are diverse, incorporating surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapies. The choice of treatment depends on factors such as the type and stage of cancer, as well as the overall health of the patient. Multidisciplinary teams comprising surgeons, medical oncologists, radiation oncologists, and other specialists collaborate to tailor treatment plans to each patient's unique needs. Gastrointestinal oncology research continually strives to identify novel therapeutic approaches and enhance our understanding of the underlying biology of these cancers. Clinical trials play a pivotal role in testing new treatments, contributing to advancements in the field and offering patients access to cutting-edge therapies. Supportive care is integral to the comprehensive management of gastrointestinal cancers. Patients may experience various physical and emotional challenges, and addressing these aspects of care is essential for improving their quality of life during and after treatment. Palliative care, pain management, nutritional support, and counseling services are vital components of a holistic approach to patient care

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp